Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost–benefit analysis

BACKGROUND: Drug-eluting stents (DESs) were considered as ground-breaking technology promising to eradicate restenosis and the necessity to perform multiple revascularization procedures subsequent to percutaneous coronary intervention. Soon after DESs were released on the market, however, there were...

Descripción completa

Detalles Bibliográficos
Autores principales: Poder, Thomas G., Erraji, Jihane, Coulibaly, Lucien P., Koffi, Kouamé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428949/
https://www.ncbi.nlm.nih.gov/pubmed/28498849
http://dx.doi.org/10.1371/journal.pone.0177476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428949/
https://www.ncbi.nlm.nih.gov/pubmed/28498849
http://dx.doi.org/10.1371/journal.pone.0177476

Ejemplares similares